Hyperliquid Q2 Report: HYPE Rises 79% to All-Time High Amid Bitcoin Decline

iconChainthink
Share
This is the logo of the coin.
HYPE
$55.70-0.56%
This is the logo of the coin.
BTC
$64,372.00-0.71%
AI summary iconSummary
The Hyperliquid Research Collective released its Q2 2026 daily market report on August 6, 2026, showing HYPE surged 79% to a new all-time high as Bitcoin declined 14%. HIP-3 real-world trading reached record levels, with stocks, commodities, and pre-IPO assets accounting for nearly one-third of volume. The first HYPE ETFs began trading in the U.S., and a private rocket company set on-chain pricing on a Saturday when the NYSE was closed. Weekly market report data confirmed the ongoing divergence between HYPE and major assets.

ChainThink reports that on August 6, the Hyperliquid Research Collective (HRC) released the Hyperliquid Q2 2026 report.

The report shows that Bitcoin fell 14% in the second quarter, while HYPE rose 79% to a new all-time high, marking its second consecutive quarter of divergence from mainstream assets.

The report states that real-world market trading on HIP-3 set a record, covering stocks, commodities, and Pre-IPO assets, accounting for nearly one-third of the platform’s total volume. Additionally, the first HYPE ETFs have begun trading in the United States;

A private rocket company achieved on-chain pricing on a Saturday when the NYSE was closed.

Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.